European Society of Toxicology In Vitro > News > ESTIV Awards at the JSAAE 2025 Congress
5 November 2025

ESTIV Awards at the JSAAE 2025 Congress

ESTIV was proud to present this year’s ESTIV Awards at the JSAAE Annual Congress 2025, recognizing outstanding contributions from early-career researchers advancing non-animal methods (NAMs) and innovative in vitro toxicology approaches.

The award committee recognized two outstanding young scientists for their exceptional oral presentations advancing the field of non-animal toxicology and Next Generation Risk Assessment (NGRA):

🥇 Yi-Ting Lai
“Case studies of NGRA strategy utilizing multiple DASS and RAx: verification in cosmetic ingredient evaluation.”

🥇 Shohei Kaneko
“Prediction of the effects of microplastics on the human body using a physiologically based pharmacokinetic (PBPK) model focusing on immune cells.”

👏 Congratulations to both awardees for their excellent scientific contributions and commitment to advancing innovative, human-relevant approaches in toxicology!

Special thanks to Dr. Yasunari Kanda (ESTIV Board Member, JSAAE liaison) — for participating in the Awards selection and for handing over the certificates to the winners during the JSAAE award ceremony of behalf of ESTIV.

Together, ESTIV and JSAAE continue to strengthen global partnerships and promote scientific excellence in in vitro and mechanistic toxicology.

🏅 These awards highlight ESTIV’s continued commitment to fostering international collaboration and supporting scientists who are shaping the future of toxicology through ethical, reliable, and human-relevant testing strategies.

A heartfelt congratulations to all the awardees and also all early-career scientists who participated in the Award contest for their inspiring work and dedication to the 3Rs principles!
👏 Your achievements continue to strengthen global ties between the European and Japanese toxicology communities.

#ESTIV #JSAAE #Awards #3Rs #InVitroToxicology #NAMs #YoungScientists #Toxicology #Collaboration

Related content

Special Issue completed – ESTIV 2024: The Application of New Approach Methodologies (NAMs) in Drug Discovery and Drug and Chemical Safety Assessment

  • News

ESTIV would like to extend its heartfelt thanks to all contributors to this special issue, which highlights some of the science and activities that took place during the congress.

ESTIV 2026 LAST-MINUTE ABSTRACT SUBMISSION OPEN

We are pleased to announce that last‑minute poster abstract submissions are now open.

Researchers who still wish to contribute are warmly invited to submit their work. The deadline for last‑minute submissions is 8 May 2026 at 23:59 CET.

ESTIV-ASCCT:  Award Winners Series: AI & Machine Learning

Check out the details on the next installment of our ESTIV – ASCCT Award Winners Webinar and make sure to register if you haven’t already. We hope to see you there!

Silver Sponsor

Communication partners

Memorandum of Understanding